Abstract
Symptoms of chronic widespread muscle pain (CWP) meet most of the diagnostic criteria for fibromyalgia syndrome, which is prevalent in females. We used an acid injection-induced muscle pain (AIMP) model to mimic CWP. After female rats received an ovariectomy (OVX), acid saline solution was injected into the left gastrocnemius muscle. Time courses of changes in pain behaviours and p-ERK in the spinal cord were compared between groups. Intrathecal injections of oestradiol (E2) to the OVX group before two acid injections and E2 or progesterone (P4) injections in male rats were compared to evaluate hormone effects. We found that repeated acid injections produced mechanical hypersensitivity and enhanced p-ERK expression in the spinal dorsal horn. OVX rats exhibited significantly less tactile allodynia than did the rats in the other groups. The ERK inhibitor U0126 alleviated mechanical allodynia with lower p-ERK expression in the sham females but did not affect the OVX rats. Intrathecal E2 reversed the attenuated mechanical hypersensitivity in the OVX group, and E2 or P4 induced transient hyperalgesia in male rats. Accordingly, our results suggested that ovarian hormones contribute to AIMP through a spinal p-ERK-mediated pathway. These findings may partially explain the higher prevalence of fibromyalgia in females than males.
Similar content being viewed by others
Introduction
Musculoskeletal pain is a major issue that is often under-diagnosed and under-treated1. Ten percent of the general population experiences chronic generalized musculoskeletal pain, particularly fibromyalgia syndrome (FMS)2,3. FMS is characterized by widespread muscle pain with tenderness, morning stiffness, disturbed sleep and mood, and pronounced fatigue2,3,4. Females, compared with males exhibit a higher incidence of FMS5 as well as increased pain and poorer quality of life6.
Several hypotheses regarding pathophysiology of CWP have been proposed, such as central sensitization7,8; pain disinhibition9,10; peripheral sensitization11; increases in nociceptive substances12; up-regulation of an acid-sensing ion channel (ASIC3) in muscle13 and in dorsal root ganglia14; and elevated cytokines levels15,16. However, none of these pathways can adequately explain the sex difference in pain pathologies.
Sluka and colleagues have developed an animal model of chronic muscle hyperalgesia by repeated intramuscular injections of acidic saline17, which characteristically induces long-lasting and widespread mechanical hyperalgesia, central sensitization, and no inflammation or peripheral tissue damage17,18,19,20,21. Currently, this model is widely used to mimic CWP or FMS in humans.
The MAPK family includes ERK, p38, and c-Jun N-terminal kinase (JNK), which play critical roles in nociceptive processing22. Among them, ERK is activated after exposure to various noxious stimuli and is involved in different pathological states under conditions including spinal nerve ligation23; bladder distension24; and hind paw injection of complete Freund’s adjuvant25, formalin26, or carrageenan27; and visceral reflex activity28,29. More recently, ERK activity has also been identified in central amygdala30 and paraventricular thalamic nucleus anterior31 in AIMP. However, no studies have investigated the role of ERK activation in sex differences and the roles in CWP.
Increasing evidence indicates the crucial influences of female hormones on pain sensitivity32,33. Recently, a rigorous study has also demonstrated the effect of 17β-oestradiol (E2) on pronociception in an acetic acid-related pain model34. Female rats treated with physiological levels of oestrogen in the trigeminal ganglia exhibited altered gene expression, thus suggesting that oestrogen regulates genes potentially relevant to migraine35. Oestradiol, the most potent oestrogen, increased NMDA-evoked rat masseter muscle afferent discharge in a dose-dependent manner36 and potentiates nocifensive responses induced by capsaicin in ovariectomized rats37. In a chronic pain state, oestradiol increases allodynia via ERK activation in trigeminal nucleus caudalis neurons (TNC)38,39. Thus, we hypothesized that the ERK signalling pathway might regulate female hormone-related widespread muscle pain.
In the present study, we aimed to elucidate the role of ERK activation and female hormones in the AIMP model. Several approaches were conducted to compare nocifensive behaviours, time-dependent p-ERK expression between normal and ovariectomized rats, and the influence of p-ERK inhibition. In addition, we performed intrathecal supplementation of E2 in the OVX females and injection of E2 or progesterone (P4) in male rats to clarify the hormonal effects on AIMP between genders. Our results revealed that ovarian hormones contribute to AIMP through a spinal p-ERK-mediated pathway.
Results
Ovariectomy results in prolonged depletion of serum 17β-oestradiol
No significant differences in serum concentrations of 17β-oestradiol were observed between the sham (Sham) and the ovariectomy groups (OVX) before surgery (baseline data 25.04 ± 9.52 pg/mL vs. 33.18 ± 10.74 pg/mL, p = 0.586, respectively, Fig. 1). Serum 17β-oestradiol was largely depleted at 3 weeks post-ovariectomy (on the day of the 1st acid injection), reaching undetectable levels (<5 pg/mL). OVX rats exhibited low 17β-oestradiol levels until 6 weeks post ovariectomy (on the 14th day after the 2nd acid injection, Fig. 1).
Deprivation of ovarian hormones ameliorates repeated AI-induced widespread pain
Repeated pH 4.0 AI induced bilateral mechanical and heat hypersensitivities in the hind limbs in ovary-intact rats (Sham group) (Fig. 2A,B). Withdrawal thresholds of both hind paws in von Frey test were markedly lower starting 3 h after the 2nd AI (P3h) and were maintained at low levels over 14 days (PD14) (Fig. 2A). In addition, thermal hyperalgesia occurred at P3h in bilateral hind paws, but the decrease was mild as compared with mechanical thresholds (Fig. 2B). Of note, Fig. 2C shows that pH 7.2 saline injection did not significantly change withdrawal thresholds. These results revealed unilateral AI-induced bilateral or widespread nociceptive hypersensitivities.
In comparison, ovariectomy (the OVX group) mitigated the mechanical allodynia induced by repeated AI (Fig. 2A) but did not alter the basal von Frey thresholds (Fig. 2C). The differences between the OVX and Sham groups appeared at P3h to PD14 in bilateral hind paws (Fig. 2A). However, no group differences in heat hyperalgesia (Fig. 2B) were noted, thus suggesting that hormonal influence may be pain type-dependent.
Repeated AI induces ERK activation in the spinal dorsal horn in a time-dependent manner
ERK1/2 (p-ERK) activation and ERK1/2 were observed in the lumbar dorsal cord after AI. Western blot analysis revealed time-dependent changes in acid-induced ERK1/2 and p-ERK1/2 in the spinal cord in the rats. (Fig. 3A) Phosphorylated ERK1/2 increased on day 1 after the 2nd injection, peaked at day 6, and declined at day 14 in the ipsilateral side (Fig. 3B). Significant differences were noted in the PD6. However, at the contralateral side, an increasing trend was observed, but the values did not significantly differ. ERK1/2 increased in the ipsilateral dorsal horn on day 1 and 6 after the 2nd injection, and only day 1 in the contralateral dorsal horn after the 2nd injection (Fig. 3C).
Deprivation of ovarian hormones decreases AI-induced ERK activation in the spinal horn
Western blotting and immunostaining were used to evaluate the effects of ovarian hormones on AI-induced ERK activation. In Fig. 4, OVX rats, compared with the Sham rats, exhibited lower p-ERK1/2 on day 1 (PD1) and lower p-ERK1 on day 6 (PD6) at the AI-side dorsal horn (Fig. 4), but no differences were observed on day 14 (PD14). Of note, no differences in p-ERK1/2 at the contralateral dorsal horn were observed at any time point. There was no difference of ERK1/2 expression between groups at any time points (Fig. S3).
To understand the distribution of ERK activation, AI-induced p-ERK-immunoreactivity at the L4 and L5 spinal segments were assessed. In Fig. 5A, immunofluorescence indicated that p-ERK-ir cells appeared on day 1 after AI and were predominantly located in the outer third of the superficial lamina (laminae I and II). Then, the cells were equally distributed at the superficial and deep (lamina III-V) layers on day 14 (Fig. 5A). Our findings were consistent with findings from numerous studies suggesting that p-ERK appears in the superficial laminae at very early stages after noxious stimulations and persists in the spinal dorsal horns23.
The immunofluorescence results revealed clear p-ERK changes. OVX rats, compared with the sham group, exhibited significantly lower p-ERK-ir cells in bilateral L4-L5 on days 1, 6, and 14 (Fig. 5B–D). OVX rats exhibited strong inhibition in both side dorsal horns on PD1 (Fig. 5B) and moderate inhibition at the superficial laminae on PD6 and at the deep laminae (III-V) on PD14 (Figs 5C,D, respectively). Notably, the distribution patterns of p-ERK were similar between the sham and OVX groups, on the basis of segments, sides, lamina, or time points. No significant difference in p-ERK was observed between groups before AI (Sham-pre vs. OVX-pre, Fig. 5B).
AI-induced p-ERK-ir cells are spinal neurons or astrocytes
On the basis of the time sequence, double staining demonstrated that p-ERK colocalized with NeuN (neurons) in the superficial laminae (I-II) and with NeuN or GFAP (astrocyte) in dorsal laminae (I-IV) throughout days 1, 6, and 14 post-AI (Fig. 6A–C). We also observed that p-ERK was first expressed within neurons on PD 1 and both astrocytes and neurons on PD14 (Fig. 6A–C). Co-expression of p-ERK and OX42 (microglia) was not noted at any time point.
Inhibition of ERK activation reverses AI-induced mechanical allodynia
We also injected the ERK inhibitor in control and OVX rats to compare the contribution of p-ERK. We found that the ovary-intact rats treated with i.t. U0126 at a dose of 10 μg on PD5 exhibited less AI-induced mechanical allodynia in the ipsilateral paw at 3 h after injection (Fig. 7A). In contrast, U0126-treated OVX rats had no evident allodynic suppression (Fig. 7B). Because the heat threshold did not clearly change in OVX rats, we did not compare the effect of U0126 on thermal thresholds. All results suggested that p-ERK may play a pivotal role in mediating ovarian hormone-dependent, AI-induced mechanical hypersensitivity.
We also examined p-ERK expression after i.t. U0126. Fluorescence staining revealed that i.t. U0126 significantly decreased p-ERK-immunoreactivity in the Sham groups (Sham-DMSO vs. Sham-U0126, Fig. 8B) but not in the OVX groups (OVX-DMSO vs. OVX-U0126, Fig. 8B). U0126 exhibited similar effects on p-ERK in the contralateral dorsal horns (Fig. 8B).
Male rats display higher mechanical thresholds and lower p-ERK1/2 expression in AIMP
To evaluate the influence of sex in AIMP and ERK activation, we compared nociceptive responses and spinal p-ERK expression in female rats with (OVX) or without (Sham) ovariectomy and male rats after AI. Male rats exhibited levels of withdrawal responses similar to those of the OVX rats, whereas higher withdrawal thresholds than those of the female sham rats were observed in both hind paws (Fig. 9A). We also analysed AI-induced p-ERK and found that male and OVX rats exhibited similar p-ERK expression on day 6 post-AI (PD6), and these levels were significantly lower than those in the female sham rats in the ipsilateral area. No contralateral side differences in p-ERK expression were observed (Fig. 9B). There was no difference of ERK1/2 expression between three groups. (Fig. S5 in the Supplementary File).
Mechanical allodynia induced by intrathecal injections of E2 and P4 in male rats
To determine whether ovarian hormones affect spinal nociceptive sensitization, we administered E2 (100 nM, 10 μL) and P4 (30 μM, 10 μL) intrathecally in the male rats. Bilateral hind paw withdrawal thresholds were markedly decreased after E2 or P4 injection at 3 h, reached the lowest level at 8 h, and then returned to baseline by 24 h (Fig. 10). In comparison, saline injection did not alter withdrawal thresholds (Fig. 10). These findings demonstrated that male rats treated with intrathecal ovarian hormones developed acute and short mechanical hypersensitivity for at least 24 h.
Replenishing ovarian hormone via intrathecal E2 recovers hypersensitivity in OVX rats
We treated the OVX females with i.t. E2 to assess whether replenishment of ovarian hormones would restore AI-induced pain. OVX females exhibited similar pain behaviours as that of the sham group after two i.t. E2 supplements (Fig. 11). Each E2 injection hypersensitized AI-induced withdrawal responses in the OVX rats back to levels analogous to those of normal female rats. The recovered sensitization persisted for at least 6 days and was present in bilateral hind paws.
Discussion
In the present study, we described ovary hormone-dependent mechanical hypersensitivity in bilateral hind paws after repeated acid injections (AIs) in the left gastrocnemius muscle. Ovariectomy decreased injection-induced bilateral allodynia and ERK activation in the spinal dorsal horn. Intrathecal injection of a p-ERK inhibitor attenuated AI-induced widespread muscle pain in the ovary-intact rats but had no effect on OVX rats. Male rats exhibited similar levels of spinal p-ERK to those in OVX after repeated AI, and exhibited temporary mechanical allodynia when they received intrathecal injection of one of two main ovarian hormones, E2 and P4. Intrathecal injection of E2 also enhanced AI-induced withdrawal responses in the OVX rats, but had no effect to normal female rats. Together, these findings indicated the roles of ovarian hormones and spinal ERK activation in nociceptive plasticity of repeated AI-induced muscle pain.
Sluka’s AIMP model can mimic fibromyalgia with central nociceptive sensitization and presentations, such as chronic, widespread, non-inflammatory pain and signs, such as fatigue40,41. These features are comorbid with anxio-depressive behaviours42. We demonstrated that after repeated AI with pH 4.0 solution but not pH 7.2 solution, the bilateral hind paws exhibited persistent hypersensitivity to mechanical stimulation for at least 14 days. These results are comparable to findings from Sluka’s report and others17,43,44. Our findings justify the application of this model to investigate the influence of sex on widespread pain.
First, we demonstrated that ovariectomy significantly attenuated mechanical allodynic responses in female rats, whereas OVX rats preserved mild AI-induced mechanical hypersensitivity, thus suggesting that ovarian hormones amplify the hyperalgesic state in AI-induced pain. Moreover, we found that E2 supplementation by intrathecal injection restored mechanical hypersensitivity in OVX rats. However, ovariectomy only partially reverse AIMP, by half. We also found that both ovarian hormones, E2 and P4, are involved, because intrathecal injection of either hormone in male rats induced mechanical hypersensitivity. Of particular note, ovariectomy per se did not alter the basal mechanical and thermal thresholds, thus indicating that the normal presence of female hormones may not determine sex differences in nociceptive thresholds. A similar concept has been postulated previously41.
Ovariectomy deprives normal sources of ovarian hormone secretion in reproductive females. We found that serum 17β-oestradiol was almost completely deprived 3 weeks after surgery and maintained at low levels for 6 weeks. The mild rebound of oestradiol levels from 3 to 6 weeks is not surprising, because ovariectomy causes increases in body weight and enrichment of fat45. Adipose tissue is another main source of peripheral oestrogens, given that high expression of the enzyme aromatase can convert androgens to oestrogens46. We therefore hypothesize that peripheral oestradiol secretion may have compensated for the deprivation and may have diminished the difference between OVX and control animals in the long term.
Clinically, female adults tend to have more pain-related diseases and are prone to higher grades of pain after injuries than do male adults. Numerous types of chronic pain are more prevalent in women, such as chronic tension headache47, migraine48, facial pain49, temporomandibular joint (TMJ) pain50, musculoskeletal pain51,52, and fibromyalgia53. Numerous animal studies have also revealed that female rodents, compared with male rodents, exhibit higher susceptibility to noxious stimuli, such as hind paw injection of formalin54, CFA55, or tail injection of capsaicin56. However, such a sex difference is not conclusive, because male rodents have greater nociceptive responses after hind paw injections of carrageenan57 and chronic constriction injury58. Whether a common mechanism contributes to female-preference pain diseases/modalities remains unknown.
In addition, OVX studies have presented inconsistent conclusions. Animals with OVX have been found to exhibit stronger abdominal hyperalgesia59, decreased pain thresholds in formalin-induced responses60,61, and glutamate-induced TMJ pain62, as compared with animals without OVX, whereas two earlier studies have reported different effects63,64. In contrast, ovary-intact rats present increased neuropathic pain65 and thermal hyperalgesia56 than do OVX rats. Another long-term survey has revealed that the OVX rats develop thermal hyperalgesia from 2 weeks to 7 weeks after OVX and mechanical allodynia at 5 weeks that persisted until 7 weeks66. Deprivation of oestrogen leading to different clinical characteristics has also been observed clinically67. These mutually contradictory studies have indicated that whether deprivation of ovarian hormones results in either pronociceptive or antinociceptive effects may depend on the types of stimuli and the duration of female hormone depletion.
The role of female hormones is unclear in females with chronic widespread muscle pain. Ovarian steroids may be a major factor determining sex-dependent nociception33,34,68,69, and oestrogen is involved in chronic pain syndromes70. Oestradiol also enhances capsaicin-induced acute pain37 and increases responsiveness to colorectal distension71. In contrast, antinociceptive actions of oestrogens have been postulated on the basis of different lines of evidence, including the observation, in long-term (8 weeks) ovariectomized mice, of persistent mechanical hyperalgesia that can be reversed by oestradiol replacement72, and the observation that oestradiol levels within physiological ranges attenuate CFA-induced TMJ pain73. In addition, during pregnancy, the maintenance of high levels of ovarian hormones decreases sensitivity to pain74,75. In the present study, we demonstrated that intrathecal injections of E2 in male rats and OVX rats produced transient mechanical allodynia (Figs 10, 11), thus demonstrating a pronociceptive effect. Again, these studies indicated that mechanism of female hormones in contributing to pronociception or antinociception is complicated and involving with multiple conditions.
Here, we provide the first report that ovarian hormone-dependent AIMP requires spinal activation of ERK. p-ERK activity was increased in the female rats early after AI and was maintained at high levels, in accordance with pain course and pain intensity. Inhibition by injection of an ERK inhibitor significantly decreased AIMP in normal female rats but had no effect on AIMP in OVX rats.
MAPK activation contributes to the initiation, development, and maintenance of nociceptive hypersensitivity in various pain models22. In particular, p-ERK is a hallmark of nociceptive sensitization in inflammatory and neuropathic pain76,77. ERK in spinal neurons is immediately activated in response to nociceptive firing, and p-ERK subsequently triggers intracellular cascades and downstream mediators, thereby resulting in central sensitization77,78. Of particular note, late ERK activation in spinal astrocytes has been suggested to maintain nociceptive sensitization and modulate long-term plasticity79. Zhuang et al.80 found that p-ERK was sequentially expressed in neurons (within hours), microglia (2 days), and astrocytes (21 days) in the superficial dorsal horn after spinal nerve ligation, and concluded that three types of cells (neuron, microglia, and astrocytes) can play distinct roles in the temporal evolution of neuropathic pain. We found similar phenomenon in this study though we did not purposely distinguish the cell-type differences.
As the precursors of p-ERK, ERK1/2 increased in the bilateral spinal cord of ovary-intact rats after acid injections. In the ipsilateral spinal dorsal horn, both p-ERK subtypes (p-ERK1 and p-ERK2) gradually increased to maximum levels on post-injection day 6, reaching a level significantly higher than pre-injection levels, and then decreased 14 days later. The changes in protein levels paralleled the increase in allodynic hypersensitivity at the injected paw, thus suggesting that ERK activation may control the development of AI-induced nociceptive behaviours. In addition, p-ERK activity may reflect expansion of sensitized receptive field, because ERK phosphorylation evenly appeared at the bilateral spinal dorsal horns for at least 2 weeks. Although western blot analysis indicated only unilateral increase in the injection-side, this finding was not surprising, because spinal p-ERK expression was clustered in small foci (i.e., lamina I and II) in proportion to the large dorsal horn mass, and differences in the contralateral side were highly diluted to an insignificant level. Such topographical identification further confirmed that AI actually induced widespread spinal sensitization.
Another intriguing finding was that p-ERK in the OVX rats was lower in comparison with that in the ovary-intact rats after acid injections, though ERK expressions in both group showed no statistical differences. In addition, the ERK inhibitor (U0126) attenuated AIMP levels in normal female rats but not in OVX rats. Further, AI-treated male rats expressed p-ERK1/2. Accordingly, p-ERK is required for female hormone-dependent AIMP in female rats and may also contribute to AIMP in male rats. Because intrathecal E2 or P4 in males induced mechanical allodynia, we thus propose that an ovarian hormone-dependent component of AIMP exists in rats, which is primarily mediated by p-ERK expression.
Min et al. have demonstrated that increased ERK activation in two supraspinal areas, the central amygdala and the paraventricular thalamic nucleus anterior, accounts for central sensitization in acid injection-induced CWP/FMS81. These authors have suggested that Cav3.2 T-type Ca2+ channel-dependent ERK activation in the paraventricular thalamus contributes to acid-induced CWP31. An increase of p-ERK in capsular central amygdaloid (CeAC) was observed in AIMP mice and involved in enhancing synaptic transmission of nociceptive parabrachio-amygdaloid (PBA) input onto CeAC30. Sluka’s group has also reported changes in phosphorylated CREB20 and concentrations of excitatory amino acids21 at the spinal cord level in acid-induced chronic hyperalgesia. Recently another evidence showing that ERK activation is involved in complicated spinal mechanisms related to microglia and astrocyte in sex-dependent pain responses82. Here, we provided new evidence by demonstrating the spinal role of p-ERK in female widespread pain and an involvement of spinal neurons and astrocytes in regulating chronic nociceptive hypersensitivity. Our results echo p-ERK functions in the brain and substantiate the importance of p-ERK in oestrogen-dependent AIMP.
Some experimental limitations might have created interpretation biases in this study. We did not thoroughly differentiate serum and CSF concentrations of E2 and P4 in OVX and normal rats, which may be critical in determining activity. The menstrual cycle may be another important factor influencing painful disorders in women. Fluctuating hormonal levels during the oestrous cycle affects pain sensitivity in rodents83. However, previous experiments has revealed that female mammals in proximity develop synchronized cycles84,85. Further, a technical limitation in this study may cause our immunostaining measurement not accurately reflect total p-ERK expression. We captured the images at a magnification of 20× objective to obtain photos at a resolution of 1936×1460 pixels and identified p-ERK-positive cells showing solid round, oval, or linear signals. This method, though carefully conducted, could still favour the inclusion of neuronal p-ERK but overlook astrocytic p-ERK because some fibrillary pERK signals in astrocytes may not be easily distinguished from the background staining. Such underestimate of astrocytic p-ERK may partially explain the different results between western blot and immunostaining.
In conclusion, this study provides the first demonstration of the involvement of ovarian hormones in an acid injection-induced muscle pain and addresses the important role of spinal ERK activation in the processes. We propose a novel perspective that ERK activation is required for ovarian hormone-dependent chronic widespread muscle pain or fibromyalgia in females. These findings may explain the sex differences in fibromyalgia and open new avenues for fibromyalgia treatment.
Materials and Methods
Animal preparation
Female and male Sprague-Dawley rats (2 months old) weighing approximately 200 g were purchased from BioLASCO (Taipei, Taiwan). Rats were housed in groups of three at 22 °C ± 1 °C with a 12-hr dark-light cycle, and food was available ad libitum. The study was performed under the approval of the Animal Care and Use Committee, China Medical University, Taichung, Taiwan and strictly followed the NIH Guidelines.
Ovariectomy and sham surgery in rats
Female rats were subjected to bilateral ovariectomy (OVX) or bilateral sham surgery (Sham) under 1% isoflurane anaesthesia. Briefly, skin incisions approximately 1 cm in length were generated 2 cm from back midline to bilateral inferior borders of the ribs. The peritoneal cavity was opened, and the bilateral ovaries were removed. The skin and muscle incisions were closed with sterile nylon sutures. The female sham and the male sham (Male) operation rats received a similar surgery except no organs were removed. After surgery, rats were allowed to recover for at least 21 days. A previous study has reported that plasma oestrogen and progesterone concentrations were largely depleted 17 days after OVX surgery86, and concentrations were even lower than those in the oestrus stage87. To confirm the success of ovariectomy, serum 17β-oestradiol levels were determined before and after ovariectomy.
Measurement of serum 17β-oestradiol (E2)
Blood samples were obtained by venipuncture of the tail under 1% isoflurane anaesthesia before bilateral ovariectomy, before the 1st acid injection (3 weeks post-surgery), and at day 14 after the 2nd acid injection (6 weeks post-surgery). The serum concentration of the unconjugated form of 17β-oestradiol was measured with a commercially available electrochemiluminescence immunoassay (ECLIA) kit “Elecsys Estradiol II” (Roche Diagnostics, Indianapolis, IN, USA). The detection limit is 5 pg/mL for ECLIA. Values below the detection limit were arbitrarily deemed 5 pg/mL for the statistical analysis.
Repeated acid solution injection (AI)-induced widespread pain
The AI-induced CWP animal model was described previously17 and was slightly modified in this study. The HCl-saline solution at pH = 4 (ranged within 3.9 and 4.1) was prepared before the study. The acid HCl solution (150 μl) was injected into the left gastrocnemius muscle in rats on day 0 (D0) and day 5 (D5).
Nociceptive behavioural tests
The mechanical threshold was evaluated by von Frey filaments (Stoelting, Wood Dale, IL). Animals were individually placed in a chamber (10 × 10 × 20 cm) of a Plexiglas cage on an elevated iron mesh floor. The von Frey filaments were applied from the mesh openings to stimulate the plantar surface by using the up-down method88. A series of von Frey filaments with logarithmically incremental stiffness (0.4, 1.0, 2.0, 4.0, 6.0, 10.0, 15.0, and 26.0 g) were presented perpendicularly to the plantar surface for 5–6 seconds for each filament. The threshold value is determined by calculation of the fifty percent withdrawal threshold89. Both hind paws were tested daily starting 2 days before the first acid injection, between two injections, and time points after the second injection. Baseline data were an average of two pre-injection measurements.
The thermal threshold was measured by paw withdrawal latencies to radiant heat stimulation. Rats were placed individually in the plantar test device (Plantar Test Apparatus, IITC, CA) with the glass floor pre-warmed to a constant 30 °C. After 15-min acclimation, a focused radiant heat source underneath the glass floor was projected to the paws. Cut-off latency was set at 30 s to avoid thermal injury. Each rat was tested three times at 5-min intervals, and the measurements were averaged to represent the withdrawal latency. Data were obtained at the same time points for the von Frey test.
Intrathecal injection of the ERK MAPK inhibitor in female rats
To investigate the involvement of ERK activation in nociceptive sensitization, i.t. injection of the ERK inhibitor U0126 (Sigma-Aldrich, Saint Louis, MO) was performed in female rats. On the 5th day after the 2nd AI (PD5), a direct dural puncture was performed at L4-5 or L5-6 interspace with a 30 G needle attached to a 25-μL Hamilton microsyringe under anaesthesia with 1% isoflurane. Correct needle placement inside the spinal thecal canal was confirmed by the appearance of a brief rapid tail flick. U0126 (10 μg in 20 μl 5% dimethyl sulphoxide, DMSO) or vehicle solution (20 μl, 5% DMSO) was then slowly injected. This i.t. dose has previously been shown to effectively inhibit complete Freund’s adjuvant-induced arthritic pain in rats90. Behavioural tests and spinal immunoassays were conducted to evaluate responses to the injection.
Intrathecal injection of ovarian hormones in male rats
To investigate the effects of ovarian hormones on nociceptive responses of male rats, water-soluble E2 (Sigma-Aldrich, Saint Louis, MO, 100 nM in 10 μl normal saline), P4 (Sigma-Aldrich, Saint Louis, MO, 30 μM in 10 μl normal saline), or vehicle solution (10 μl, saline) was slowly i.t. injected into the L4-5 or L5-6 interspace in male rats. These E291 and P492 i.t. doses have been shown to facilitate the repetitive stimulation-induced spinal reflex effectively. Behavioural tests were conducted to evaluate responses to the injection.
Intrathecal injection of ovarian hormones in OVX female rats
To investigate the effects of ovarian hormones on nociceptive responses of female rats, water-soluble E2 (Sigma-Aldrich, Saint Louis, MO, 100 nM in 10 μl normal saline) or vehicle solution (10 μl, saline) was twice injected into the L4-5 or L5-6 interspace in OVX female rats. Each E2 delivery was conducted one day before acid injection. Behavioural tests were conducted to evaluate responses to the injection.
Western blotting
Animals were anaesthetized with a high concentration of isoflurane and sacrificed. The bilateral dorsal spinal cord at L4-5 segments was dissected. Tissue lysates were prepared by homogenization and fractionation into cytosolic, membrane, and nuclear fractions using a cytoplasmic, nuclear, and membrane compartment protein extraction kit, as recommended by the manufacturer (Biochain Institute, Inc., Hayward, Calif). Each cytosolic protein sample (20 μg) was separated on a 8 or 10% polyacrylamide-SDS gel in a glycine-Tris buffer, transferred to a PVDF membrane, and probed with rabbit anti-ERK and anti-p-ERK antibodies (1:1,000, Cell Signaling Technology, Danvers, MA) at 4 °C overnight. The immune complexes were further probed with a HRP-conjugated anti-rabbit IgG secondary antibody (1:5000, Jackson ImmunoResearch, West Grove, PA) and then visualized with HRP-reactive chemiluminescence reagents (Millipore Corporation, Billerica, Massachusetts, USA). The chemiluminescent band was detected and analysed with an ImageQuant LAS 4000 imaging system (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The band intensity of each group was normalized to that of GAPDH, and values are presented as the fold-change compared with control for statistical analysis. All the western blots were performed under a standardized procedure.
Immunofluorescence staining
Rats were deeply anaesthetized and perfused intracardially with 4% paraformaldehyde in phosphate-buffered saline. The lumbar spinal cord was removed and cut into 30-μm transverse sections in a cryostat (LEICA CM3050S, Nussloch, Germany). After being washed with Tris-buffered saline (TBS), sections were blocked with 3% normal goat serum in TBS for 1 h and then incubated with rabbit anti-p-ERK antibody (1:400; Cell Signaling Technology, Danvers, MA) at 4 °C overnight. Sections were then reacted with Cy3-conjugated secondary antibody (1:400, Jackson ImmunoResearch, West Grove, PA) for 1 h at room temperature. For double staining, sections were incubated with a mixture of anti-p-ERK (1:400) and anti-NeuN (neuronal marker, 1:1500; Chemicon, Temecula, CA), anti-OX-42 (microglia marker, 1:200; Serotec, Indianapolis, IN), or anti-GFAP (astrocyte marker, 1:6000; Chemicon) antibodies from different species and then reacted with a mixture of Alexa 488- and Cy3-conjugated secondary antibodies (1:400, Jackson ImmunoResearch, West Grove, PA). Slides were air-dried and dehydrated, and cover slips were applied. All section images were captured using a CCD camera (ZEISS Axiocam 105 colour, Jena, Germany) connected to a Zeiss Axio Imager A2 microscope (Göttingen, German) or spectral confocal microscopy (Leica SP2, MAJOR, Germany), and the fluorescence intensity of the spinal section was analysed using ImageJ (1.47 v, NIH Image, National Institutes of Health, Bethesda, MD). All images were captured under a 20× objective in a square box (450 × 338 μm) using a standardized microscopic setting to obtain an image at a resolution of 1936 × 1460 pixels, and the top line of the square was parallel with the edge of the dorsal horn grey matter. The size of the box includes the medial two-thirds of the dorsal horn (laminae I–V) to represent the interested region where most p-ERK–immunoreactive (ir) cells were expressed after acid-injections. We calculated p-ERK-ir cells by Rexed laminae (I-V) on randomly chosen sections, using at least 8 for each spinal segment, and values were averaged for analysis. To have consistent results, all images were followed a standardized brightness adjustment and were universally converted to 8-bit greyscale. We defined positive cells which have solid round, oval, or linear morphology and distinct signals from background noise to show bright signal/noise ratio >2. For S/N ratio, we compared the intensity of a manually circled bright signals, the region of interest (ROI), with that of a dark spot with the same size and shape at adjacent background. Colocalization analysis used images taken by confocal microscope to have better resolution. The observer was unaware of the treatments during counting.
Study deign
Experiment 1: Effect of ovariectomy on AIMP in female rats
The sham group and the ovariectomy (OVX) group were both subjected to repeated AI 3 weeks after surgery. Behavioural tests were conducted before AI as baseline (BL) data; immediately before the first AI (D0) and second AI (D5); and at 3 hours, day 1, day 3, day 6, day 8, and day 14 after the second AI.
Experiment 2: Role of ERK activation in AIMP
The Sham and OVX rats were sacrificed on days 1, 6, and 14 after the 2nd AI for immunostaining and western blot analysis. In addition, the Sham or OVX groups received i.t. injections of 10 μg of U0126 or 20 μL of 10 μg vehicle on Day 5 after 2nd AI (PD5) to assess behavioural and p-ERK responses.
Experiment 3: Sex effects on AIMP and ERK activation
Behavioural and p-ERK responses to repeated AIs were compared among the Sham, OVX, and sham male rats. In a separate study, E2 was i.t. injected to OVX rats to detect the hormonal effect in the AIMP model. Simultaneously, E2 and P4 were i.t. injected in male rats to evaluate the effects of ovarian hormones on pain responses.
Statistical analysis
Data are presented as the mean ± standard error of the mean (SEM). Behavioural observations were analysed by two-way repeated measures- (RM-) ANOVA followed by post hoc Tukey’s test for group differences and one-way RM ANOVA for time course change. Relative protein expression levels and immunoreactive cell counts at different time points were analysed by one-way ANOVA and followed by post hoc Tukey’s test or unpaired Student’s t-test when appropriate for multiple groups. Statistical software GraphPad Prism v.2 (GraphPad Software, Inc., San Diego, CA) was used for calculation. Differences were considered significant when the p-value was less than 0.05.
References
Caudill-Slosberg, M. A., Schwartz, L. M. & Woloshin, S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 109, 514–519, https://doi.org/10.1016/j.pain.2004.03.006 (2004).
Wolfe, F. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and rheumatism 33, 160–172 (1990).
Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis care & research 62, 600–610, https://doi.org/10.1002/acr.20140 (2010).
Boissevain, M. D. & McCain, G. A. Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects. Pain 45, 227–238 (1991).
Bartels, E. M. et al. Fibromyalgia, diagnosis and prevalence. Are gender differences explainable? Ugeskrift for laeger 171, 3588–3592 (2009).
Staud, R. Peripheral pain mechanisms in chronic widespread pain. Best practice & research. Clinical rheumatology 25, 155–164, https://doi.org/10.1016/j.berh.2010.01.010 (2011).
Bendtsen, L., Norregaard, J., Jensen, R. & Olesen, J. Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis and rheumatism 40, 98–102 (1997).
Price, D. D. et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99, 49–59 (2002).
Ren, K. & Dubner, R. Descending modulation in persistent pain: an update. Pain 100, 1–6 (2002).
Julien, N., Goffaux, P., Arsenault, P. & Marchand, S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114, 295–302, https://doi.org/10.1016/j.pain.2004.12.032 (2005).
Elvin, A., Siosteen, A. K., Nilsson, A. & Kosek, E. Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: a contrast media enhanced colour Doppler study. European journal of pain 10, 137–144, https://doi.org/10.1016/j.ejpain.2005.02.001 (2006).
Rosendal, L. et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain 112, 324–334, https://doi.org/10.1016/j.pain.2004.09.017 (2004).
Sluka, K. A. et al. ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation. Pain 129, 102–112, https://doi.org/10.1016/j.pain.2006.09.038 (2007).
Ikeuchi, M., Kolker, S. J., Burnes, L. A., Walder, R. Y. & Sluka, K. A. Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice. Pain 137, 662–669, https://doi.org/10.1016/j.pain.2008.01.020 (2008).
Wallace, D. J. et al. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40, 743–749 (2001).
Salemi, S. et al. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. The Journal of rheumatology 30, 146–150 (2003).
Sluka, K. A., Kalra, A. & Moore, S. A. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle & nerve 24, 37–46 (2001).
Tillu, D. V., Gebhart, G. F. & Sluka, K. A. Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult. Pain 136, 331–339, https://doi.org/10.1016/j.pain.2007.07.011 (2008).
Skyba, D. A., King, E. W. & Sluka, K. A. Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline. Pain 98, 69–78 (2002).
Hoeger-Bement, M. K. & Sluka, K. A. Phosphorylation of CREB and mechanical hyperalgesia is reversed by blockade of the cAMP pathway in a time-dependent manner after repeated intramuscular acid injections. The. Journal of neuroscience: the official journal of the Society for Neuroscience 23, 5437–5445 (2003).
Skyba, D. A., Lisi, T. L. & Sluka, K. A. Excitatory amino acid concentrations increase in the spinal cord dorsal horn after repeated intramuscular injection of acidic saline. Pain 119, 142–149, https://doi.org/10.1016/j.pain.2005.09.025 (2005).
Ji, R. R., Gereau, R. W., Malcangio, M. & Strichartz, G. R. MAP kinase and pain. Brain Res Rev 60, 135–148, https://doi.org/10.1016/j.brainresrev.2008.12.011 (2009).
Lin, M. L. et al. Pulsed radiofrequency inhibited activation of spinal mitogen-activated protein kinases and ameliorated early neuropathic pain in rats. European journal of pain 18, 659–670 (2014).
Cruz, C. D., Avelino, A., McMahon, S. B. & Cruz, F. Increased spinal cord phosphorylation of extracellular signal-regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation. The European journal of neuroscience 21, 773–781, https://doi.org/10.1111/j.1460-9568.2005.03893.x (2005).
Ji, R. R., Befort, K., Brenner, G. J. & Woolf, C. J. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. Journal of Neuroscience 22, 478–485 (2002).
Fukuda, T., Hisano, S. & Tanaka, M. Licking decreases phosphorylation of extracellular signal-regulated kinase in the dorsal horn of the spinal cord after a formalin test. Anesthesia and analgesia 109, 1318–1322, https://doi.org/10.1213/ane.0b013e3181b0fe05 (2009).
Galan, A., Lopez-Garcia, J. A., Cervero, F. & Laird, J. M. Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents. Neuroscience letters 322, 37–40 (2002).
Obata, K. & Noguchi, K. MAPK activation in nociceptive neurons and pain hypersensitivity. Life sciences 74, 2643–2653, https://doi.org/10.1016/j.lfs.2004.01.007 (2004).
Cruz, C. D. & Cruz, F. The ERK 1 and 2 pathway in the nervous system: from basic aspects to possible clinical applications in pain and visceral dysfunction. Current neuropharmacology 5, 244–252, https://doi.org/10.2174/157015907782793630 (2007).
Cheng, S. J. et al. Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice. The Journal of neuroscience: the official journal of the Society for Neuroscience 31, 2258–2270, https://doi.org/10.1523/JNEUROSCI.5564-10.2011 (2011).
Chen, W. K. et al. Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. The. Journal of neuroscience: the official journal of the Society for Neuroscience 30, 10360–10368, https://doi.org/10.1523/JNEUROSCI.1041-10.2010 (2010).
Mogil, J. S. Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nature reviews. Neuroscience 13, 859–866, https://doi.org/10.1038/nrn3360 (2012).
Gintzler, A. R. & Liu, N. J. Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors. Frontiers in neuroendocrinology 33, 412–424, https://doi.org/10.1016/j.yfrne.2012.09.004 (2012).
Qu, Z. W. et al. 17beta-Estradiol Enhances ASIC Activity in Primary Sensory Neurons to Produce Sex Difference in Acidosis-Induced Nociception. Endocrinology 156, 4660–4671, https://doi.org/10.1210/en.2015-1557 (2015).
Puri, V. et al. Effects of oestrogen on trigeminal ganglia in culture: implications for hormonal effects on migraine. Cephalalgia: an international journal of headache 26, 33–42, https://doi.org/10.1111/j.1468-2982.2005.00987.x (2006).
Dong, X. D. et al. Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge result from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience 146, 822–832, https://doi.org/10.1016/j.neuroscience.2007.01.051 (2007).
Lu, Y. C., Chen, C. W., Wang, S. Y. & Wu, F. S. 17Beta-estradiol mediates the sex difference in capsaicin-induced nociception in rats. The Journal of pharmacology and experimental therapeutics 331, 1104–1110, https://doi.org/10.1124/jpet.109.158402 (2009).
Tashiro, A., Okamoto, K. & Bereiter, D. A. Chronic inflammation and estradiol interact through MAPK activation to affect TMJ nociceptive processing by trigeminal caudalis neurons. Neuroscience 164, 1813–1820, https://doi.org/10.1016/j.neuroscience.2009.09.058 (2009).
Liverman, C. S. et al. Oestrogen increases nociception through ERK activation in the trigeminal ganglion: evidence for a peripheral mechanism of allodynia. Cephalalgia: an international journal of headache 29, 520–531, https://doi.org/10.1111/j.1468-2982.2008.01755.x (2009).
DeSantana, J. M., da Cruz, K. M. & Sluka, K. A. Animal models of fibromyalgia. Arthritis research & therapy 15, 222, https://doi.org/10.1186/ar4402 (2013).
Gregory, N. S., Gibson-Corley, K., Frey-Law, L. & Sluka, K. A. Fatigue-enhanced hyperalgesia in response to muscle insult: induction and development occur in a sex-dependent manner. Pain 154, 2668–2676, https://doi.org/10.1016/j.pain.2013.07.047 (2013).
Liu, Y. T., Shao, Y. W., Yen, C. T. & Shaw, F. Z. Acid-induced hyperalgesia and anxio-depressive comorbidity in rats. Physiology & behavior 131, 105–110, https://doi.org/10.1016/j.physbeh.2014.03.030 (2014).
Ambalavanar, R., Yallampalli, C., Yallampalli, U. & Dessem, D. Injection of adjuvant but not acidic saline into craniofacial muscle evokes nociceptive behaviors and neuropeptide expression. Neuroscience 149, 650–659, https://doi.org/10.1016/j.neuroscience.2007.07.058 (2007).
Gandhi, R., Ryals, J. M. & Wright, D. E. Neurotrophin-3 reverses chronic mechanical hyperalgesia induced by intramuscular acid injection. The Journal of neuroscience: the official journal of the Society for Neuroscience 24, 9405–9413, https://doi.org/10.1523/JNEUROSCI.0899-04.2004 (2004).
Wegorzewska, I. N. et al. Postovariectomy weight gain in female rats is reversed by estrogen receptor alpha agonist, propylpyrazoletriol. American journal of obstetrics and gynecology 199(67), e61–65, https://doi.org/10.1016/j.ajog.2007.11.054 (2008).
Nelson, L. R. & Bulun, S. E. Estrogen production and action. Journal of the American Academy of Dermatology 45, S116–124 (2001).
Rasmussen, B. K. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 53, 65–72 (1993).
Weitzel, K. W., Strickland, J. M., Smith, K. M. & Goode, J. V. Gender-specific issues in the treatment of migraine. The journal of gender-specific medicine: JGSM: the official journal of the Partnership for Women’s Health at Columbia 4, 64–74 (2001).
Gazerani, P., Andersen, O. K. & Arendt-Nielsen, L. A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain 118, 155–163, https://doi.org/10.1016/j.pain.2005.08.009 (2005).
Johansson, A., Unell, L., Carlsson, G. E., Soderfeldt, B. & Halling, A. Gender difference in symptoms related to temporomandibular disorders in a population of 50-year-old subjects. Journal of orofacial pain 17, 29–35 (2003).
Andersson, H. I., Ejlertsson, G., Leden, I. & Rosenberg, C. Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. The Clinical journal of pain 9, 174–182 (1993).
Treaster, D. E. & Burr, D. Gender differences in prevalence of upper extremity musculoskeletal disorders. Ergonomics 47, 495–526, https://doi.org/10.1080/00140130310001638171 (2004).
Schuna, A. A. Autoimmune rheumatic diseases in women. Journal of the American Pharmaceutical Association 42, 612–623, quiz 623–614 (2002).
Gaumonda, I., Arsenaultb, P. & Marchanda, S. The role of sex hormones on formalin-induced nociceptive responses. Brain Research 958, 139–145 (2002).
Bradshaw, H., Miller, J., Ling, Q., Malsnee, K. & Ruda, M. A. Sex differences and phases of the estrous cycle alter the response of spinal cord dynorphin neurons to peripheral inflammation and hyperalgesia. Pain 85, 93–99 (2000).
Barrett, A. C., Smith, E. S. & Picker, M. J. Capsaicin-induced hyperalgesia and mu-opioid-induced antihyperalgesia in male and female Fischer 344 rats. The Journal of pharmacology and experimental therapeutics 307, 237–245, https://doi.org/10.1124/jpet.103.054478 (2003).
Tall, J. M. & Crisp, T. Effects of gender and gonadal hormones on nociceptive responses to intraplantar carrageenan in the rat. Neuroscience letters 354, 239–241 (2004).
Tall, J. M., Stuesse, S. L., Cruce, W. L. & Crisp, T. Gender and the behavioral manifestations of neuropathic pain. Pharmacology, biochemistry, and behavior 68, 99–104 (2001).
Sanoja, R. & Cervero, F. Estrogen-dependent abdominal hyperalgesia induced by ovariectomy in adult mice: a model of functional abdominal pain. Pain 118, 243–253, https://doi.org/10.1016/j.pain.2005.08.021 (2005).
Ceccarelli, I., Fiorenzani, P., Massafra, C. & Aloisi, A. M. Long-term ovariectomy changes formalin-induced licking in female rats: the role of estrogens. Reproductive biology and endocrinology: RB&E 1, 24 (2003).
Mannino, C. A., South, S. M., Quinones-Jenab, V. & Inturrisi, C. E. Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test. The journal of pain: official journal of the American Pain. Society 8, 334–342, https://doi.org/10.1016/j.jpain.2006.10.002 (2007).
Fischer, L. et al. The influence of sex and ovarian hormones on temporomandibular joint nociception in rats. The journal of pain: official journal of the American Pain. Society 9, 630–638, https://doi.org/10.1016/j.jpain.2008.02.006 (2008).
Beatty, W. W. & Fessler, R. G. Gonadectomy and sensitivity to electric shock in the rat. Physiology & behavior 19, 1–6 (1977).
Mogil, J. S., Sternberg, W. F., Kest, B., Marek, P. & Liebeskind, J. C. Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain 53, 17–25 (1993).
Coyle, D. E., Sehlhorst, C. S. & Mascari, C. Female rats are more susceptible to the development of neuropathic pain using the partial sciatic nerve ligation (PSNL) model. Neuroscience letters 186, 135–138 (1995).
Li, L. H., Wang, Z. C., Yu, J. & Zhang, Y. Q. Ovariectomy results in variable changes in nociception, mood and depression in adult female rats. PloS one 9, e94312, https://doi.org/10.1371/journal.pone.0094312 (2014).
Martinez-Jauand, M. et al. Age-of-onset of menopause is associated with enhanced painful and non-painful sensitivity in fibromyalgia. Clinical rheumatology 32, 975–981, https://doi.org/10.1007/s10067-013-2212-8 (2013).
Craft, R. M., Mogil, J. S. & Aloisi, A. M. Sex differences in pain and analgesia: the role of gonadal hormones. European journal of pain 8, 397–411, https://doi.org/10.1016/j.ejpain.2004.01.003 (2004).
Berkley, K. J. Sex differences in pain. The Behavioral and brain sciences 20, 371–380, discussion 435–513 (1997).
Craft, R. M. Modulation of pain by estrogens. Pain 132(Suppl 1), S3–12, https://doi.org/10.1016/j.pain.2007.09.028 (2007).
Ji, Y., Murphy, A. Z. & Traub, R. J. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. The Journal of neuroscience: the official journal of the Society for Neuroscience 23, 3908–3915 (2003).
Klinger, M. B., Sacks, S. & Cervero, F. A role for extracellular signal-regulated kinases 1 and 2 in the maintenance of persistent mechanical hyperalgesia in ovariectomized mice. Neuroscience 172, 483–493, https://doi.org/10.1016/j.neuroscience.2010.10.043 (2011).
Kramer, P. R. & Bellinger, L. L. The effects of cycling levels of 17beta-estradiol and progesterone on the magnitude of temporomandibular joint-induced nociception. Endocrinology 150, 3680–3689, https://doi.org/10.1210/en.2008-1707 (2009).
Gintzler, A. R. Endorphin-mediated increases in pain threshold during pregnancy. Science 210, 193–195 (1980).
Carvalho, B. et al. Experimental heat pain for detecting pregnancy-induced analgesia in humans. Anesthesia and analgesia 103, 1283–1287, https://doi.org/10.1213/01.ane.0000239224.48719.28 (2006).
Lin, J. G. et al. The effect of high and low frequency electroacupuncture in pain after lower abdominal surgery. Pain 99, 509–514 (2002).
Ji, R. R., Baba, H., Brenner, G. J. & Woolf, C. J. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2, 1114–1119, https://doi.org/10.1038/16040 (1999).
Kawasaki, Y. et al. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 24, 8310–8321, https://doi.org/10.1523/JNEUROSCI.2396-04.200424/38/8310 (2004).
Jiang, B. C. et al. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. J Clin Invest 126, 745–761, https://doi.org/10.1172/JCI81950 (2016).
Zhuang, Z. Y., Gerner, P., Woolf, C. J. & Ji, R. R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149–159, https://doi.org/10.1016/j.pain.2004.12.022 (2005).
Min, M. Y. et al. ERK, synaptic plasticity and acid-induced muscle pain. Communicative & integrative biology 4, 394–396, https://doi.org/10.4161/cib.4.4.15694 (2011).
Chen, G., Luo, X., Qadri, M. Y., Berta, T. & Ji, R. R. Sex-Dependent Glial Signaling in Pathological Pain: Distinct Roles of Spinal Microglia and Astrocytes. Neurosci Bull, https://doi.org/10.1007/s12264-017-0145-y (2017).
Martin, V. T. Ovarian hormones and pain response: a review of clinical and basic science studies. Gender medicine 6(Suppl 2), 168–192, https://doi.org/10.1016/j.genm.2009.03.006 (2009).
McClintock, M. K. Estrous synchrony and its mediation by airborne chemical communication (Rattus norvegicus). Hormones and behavior 10, 264–275 (1978).
Ims, R. A. The ecology and evolution of reproductive synchrony. Trends in ecology & evolution 5, 135–140, https://doi.org/10.1016/0169-5347(90)90218-3 (1990).
Liu, J. W., Dawson, D. D., Peters, C. E., Baker, M. A. & Walker, A. M. Estrogen replacement in ovariectomized rats results in physiologically significant levels of circulating progesterone, and co-administration of progesterone markedly reduces the circulating estrogen. Endocrine 6, 125–131, https://doi.org/10.1007/BF02738955 (1997).
Butcher, R. L., Collins, W. E. & Fugo, N. W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 94, 1704–1708, https://doi.org/10.1210/endo-94-6-1704 (1974).
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M. & Yaksh, T. L. Quantitative assessment of tactile allodynia in the rat paw. Journal of neuroscience methods 53, 55–63 (1994).
Dixon, W. J. Efficient analysis of experimental observations. Annual review of pharmacology and toxicology 20, 441–462, https://doi.org/10.1146/annurev.pa.20.040180.002301 (1980).
Seino, D. et al. The role of ERK signaling and the P2X receptor on mechanical pain evoked by movement of inflamed knee joint. Pain 123, 193–203, https://doi.org/10.1016/j.pain.2006.02.032 (2006).
Peng, H. Y. et al. Estrogen-dependent facilitation on spinal reflex potentiation involves the Cdk5/ERK1/2/NR2B cascade in anesthetized rats. American journal of physiology. Endocrinology and metabolism 297, E416–426, https://doi.org/10.1152/ajpendo.00129.2009 (2009).
Chang, J. L. et al. Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission. American journal of physiology. Renal physiology 299, F43–48, https://doi.org/10.1152/ajprenal.00632.2009 (2010).
Acknowledgements
Special thanks to Dr. Chih-Cheng Chen (Institute of Biomedical Sciences, Academia Sinica) for critical review of this manuscript, and Dr. Yi-Wen Lin for his precious contribution in advises of our immunostaining in this revision. We also thank Ya-Hsin Lou for technical and official assistance. This study was supported by China Medical University under the aim for Top University Plan of the Ministry of Education, Taiwan. This study was sponsored by research grants from the Ministry of Science and Technology (MOST 104-2314-B-039-020-MY2) and China Medical University Hospital supporting grant (DMR-106-217), and was partially supported by grants from the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), the Aim for Top University Plan of the Ministry of Education for CMU, and the National Science Council to Y.-R. Wen (NSC 101-2314-B-039-005-MY3), as well as grants from the National Science Council to J. H. Chang (MOST 104-2314-B-039-033) and to S.Y. Tsai (NSC 99-2314-B-038-008-MY2), and from China Medical University Hospital supporting grant (DMR-105-167) to J. H. Chang. This work was supported by grants from the Ministry of Health and Welfare, Taiwan(MOHW107-TDU-B-212-123004).
Author information
Authors and Affiliations
Contributions
Y.R.W. conceived the study. J.H.C. analysed data and wrote the manuscript. S.Y.T. and Y.J.Z. performed experiments and revised the manuscript. Y.C.L., C.Y.L. and K.B.C. revised the manuscript. All authors had final approval of the submitted and published versions.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chang, JH., Tsai, SY., Zeng, YJ. et al. Ovarian Hormone-dependent and Spinal ERK Activation-regulated Nociceptive Hypersensitivity in Female Rats with Acid Injection-induced Chronic Widespread Muscle Pain. Sci Rep 9, 3077 (2019). https://doi.org/10.1038/s41598-019-39472-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-39472-z
- Springer Nature Limited